Literature DB >> 19081593

Papillomavirus E6 proteins.

Heather L Howie1, Rachel A Katzenellenbogen, Denise A Galloway.   

Abstract

The papillomaviruses are small DNA viruses that encode approximately eight genes, and require the host cell DNA replication machinery for their viral DNA replication. Thus papillomaviruses have evolved strategies to induce host cell DNA synthesis balanced with strategies to protect the cell from unscheduled replication. While the papillomavirus E1 and E2 genes are directly involved in viral replication by binding to and unwinding the origin of replication, the E6 and E7 proteins have auxillary functions that promote proliferation. As a consequence of disrupting the normal checkpoints that regulate cell cycle entry and progression, the E6 and E7 proteins play a key role in the oncogenic properties of human papillomaviruses with a high risk of causing anogenital cancers (HR HPVs). As a consequence, E6 and E7 of HR HPVs are invariably expressed in cervical cancers. This article will focus on the E6 protein and its numerous activities including inactivating p53, blocking apoptosis, activating telomerase, disrupting cell adhesion, polarity and epithelial differentiation, altering transcription and reducing immune recognition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19081593      PMCID: PMC2674106          DOI: 10.1016/j.virol.2008.11.017

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  154 in total

1.  Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases.

Authors:  N A Barlev; L Liu; N H Chehab; K Mansfield; K G Harris; T D Halazonetis; S L Berger
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

Review 2.  The expanding role of mitochondria in apoptosis.

Authors:  X Wang
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

Review 3.  The human papillomavirus E6 protein and its contribution to malignant progression.

Authors:  F Mantovani; L Banks
Journal:  Oncogene       Date:  2001-11-26       Impact factor: 9.867

4.  Interaction of zyxin, a focal adhesion protein, with the e6 protein from human papillomavirus type 6 results in its nuclear translocation.

Authors:  Y Y Degenhardt; S Silverstein
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase.

Authors:  Qingshen Gao; Ajay Kumar; Latika Singh; Jon M Huibregtse; Sylvie Beaudenon; Seetha Srinivasan; David E Wazer; Hamid Band; Vimla Band
Journal:  Cancer Res       Date:  2002-06-01       Impact factor: 12.701

6.  The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis.

Authors:  Maria Filippova; Helen Song; Jodi L Connolly; Terence S Dermody; Penelope J Duerksen-Hughes
Journal:  J Biol Chem       Date:  2002-04-04       Impact factor: 5.157

7.  Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation.

Authors:  Miranda Thomas; Richard Laura; Karin Hepner; Ernesto Guccione; Charles Sawyers; Laurence Lasky; Lawrence Banks
Journal:  Oncogene       Date:  2002-08-01       Impact factor: 9.867

8.  Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3.

Authors:  Ajay Kumar; Yongtong Zhao; Gaoyuan Meng; Musheng Zeng; Seetha Srinivasan; Laurie M Delmolino; Qingshen Gao; Goberdhan Dimri; Georg F Weber; David E Wazer; Hamid Band; Vimla Band
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  The DNA repair protein, O(6)-methylguanine-DNA methyltransferase is a proteolytic target for the E6 human papillomavirus oncoprotein.

Authors:  Kalkunte S Srivenugopal; Francis Ali-Osman
Journal:  Oncogene       Date:  2002-08-29       Impact factor: 9.867

10.  Dual regulation of telomerase activity through c-Myc-dependent inhibition and alternative splicing of hTERT.

Authors:  Ana Cerezo; Holger Kalthoff; Markus Schuermann; Birgit Schäfer; Petra Boukamp
Journal:  J Cell Sci       Date:  2002-03-15       Impact factor: 5.285

View more
  131 in total

Review 1.  Estrogen and ERalpha: culprits in cervical cancer?

Authors:  Sang-Hyuk Chung; Silvia Franceschi; Paul F Lambert
Journal:  Trends Endocrinol Metab       Date:  2010-04-22       Impact factor: 12.015

Review 2.  [HPV-associated squamous cell carcinogenesis].

Authors:  G Assmann; K Sotlar
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

Review 3.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

4.  Differential in vitro immortalization capacity of eleven (probable) [corrected] high-risk human papillomavirus types.

Authors:  Denise M Schütze; Peter J F Snijders; Leontien Bosch; Duco Kramer; Chris J L M Meijer; Renske D M Steenbergen
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

Review 5.  Recent advances in the study of HPV-associated carcinogenesis.

Authors:  Liyan Jin; Zhi-Xiang Xu
Journal:  Virol Sin       Date:  2015-04-20       Impact factor: 4.327

Review 6.  Papillomavirus prophylactic vaccines: established successes, new approaches.

Authors:  M Saveria Campo; Richard B S Roden
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

7.  Destabilization of Rb by human papillomavirus E7 is cell cycle dependent: E2-25K is involved in the proteolysis.

Authors:  Kwang-Jin Oh; Anna Kalinina; Srilata Bagchi
Journal:  Virology       Date:  2009-11-10       Impact factor: 3.616

Review 8.  Impact of Replication Stress in Human Papillomavirus Pathogenesis.

Authors:  Cary A Moody
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

9.  EGFR signaling downstream of EGF regulates migration, invasion, and MMP secretion of immortalized cells derived from human ameloblastoma.

Authors:  Marina Rolo Pinheiro da Rosa; Aline Semblano Carreira Falcão; Hellen Thais Fuzii; Maria Sueli da Silva Kataoka; André L R Ribeiro; Enrique Boccardo; Adriane Sousa de Siqueira; Ruy G Jaeger; João de Jesus Viana Pinheiro; Sérgio de Melo Alves Júnior
Journal:  Tumour Biol       Date:  2014-08-07

10.  Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.

Authors:  Paweena Chunharojrith; Yuki Nakayama; Xiaobing Jiang; Rachel E Kery; Jun Ma; Cristine S De La Hoz Ulloa; Xun Zhang; Yunli Zhou; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2015-08-15       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.